World Markets
JNJ

Johnson & Johnson to buy private robotics firm Auris for $3.4 bln

Reuters

Feb 13 () - Johnson & Johnson is buying privately held surgical robotics company Auris Health Inc for about $3.4 billion in cash, the healthcare conglomerate said on Wednesday, as it continues its push into robotics.

The agreement includes additional payments by J&J of $2.35 billion, contingent upon Auris reaching certain milestones, J&J said, without elaborating.

Auris Health is a developer of robotic technologies focused on lung cancer. The deal follows J&J's acquisition last year of Orthotaxy, a privately held developer of software-enabled surgery technologies.

The acquisition is expected to close by the end of the second quarter of 2019.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

JNJ

Other Topics

Stocks

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More